Business Description
Shanxi Zhendong Pharmaceutical Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE100000YR9
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 785.49 | |||||
Equity-to-Asset | 0.87 | |||||
Debt-to-EBITDA | 0.39 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 4.42 | |||||
Beneish M-Score | -1.99 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -9.2 | |||||
3-Year EBITDA Growth Rate | -44.9 | |||||
3-Year Book Growth Rate | -2.8 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 47.2 | |||||
9-Day RSI | 46.18 | |||||
14-Day RSI | 45.73 | |||||
6-1 Month Momentum % | 28.1 | |||||
12-1 Month Momentum % | -18.52 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.4 | |||||
Quick Ratio | 3.91 | |||||
Cash Ratio | 2.43 | |||||
Days Inventory | 272.4 | |||||
Days Sales Outstanding | 75.29 | |||||
Days Payable | 90.43 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | 0.23 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 50.35 | |||||
Operating Margin % | -1.66 | |||||
Net Margin % | -0.1 | |||||
FCF Margin % | -13.31 | |||||
ROE % | -0.06 | |||||
ROA % | -0.05 | |||||
ROIC % | 3.9 | |||||
3-Year ROIIC % | 14.38 | |||||
ROC (Joel Greenblatt) % | 0.27 | |||||
ROCE % | 0.11 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shiller PE Ratio | 11.28 | |||||
PS Ratio | 1.5 | |||||
PB Ratio | 0.86 | |||||
Price-to-Tangible-Book | 0.96 | |||||
EV-to-EBIT | 469.26 | |||||
EV-to-EBITDA | 469.26 | |||||
EV-to-Revenue | 0.87 | |||||
EV-to-FCF | -6.06 | |||||
Price-to-Projected-FCF | 1.18 | |||||
Price-to-Median-PS-Value | 1.01 | |||||
Price-to-Net-Current-Asset-Value | 1.39 | |||||
Price-to-Net-Cash | 4.36 | |||||
Earnings Yield (Greenblatt) % | 0.21 | |||||
FCF Yield % | -9.36 | |||||
Forward Rate of Return (Yacktman) % | 18.45 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Shanxi Zhendong Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 3,111.696 | ||
EPS (TTM) (Â¥) | -0.003 | ||
Beta | 0.81 | ||
Volatility % | 44.22 | ||
14-Day RSI | 45.73 | ||
14-Day ATR (Â¥) | 0.254016 | ||
20-Day SMA (Â¥) | 4.5715 | ||
12-1 Month Momentum % | -18.52 | ||
52-Week Range (Â¥) | 3.13 - 6.61 | ||
Shares Outstanding (Mil) | 1,005.32 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Shanxi Zhendong Pharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Shanxi Zhendong Pharmaceutical Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Shanxi Zhendong Pharmaceutical Co Ltd Frequently Asked Questions
What is Shanxi Zhendong Pharmaceutical Co Ltd(SZSE:300158)'s stock price today?
When is next earnings date of Shanxi Zhendong Pharmaceutical Co Ltd(SZSE:300158)?
Does Shanxi Zhendong Pharmaceutical Co Ltd(SZSE:300158) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |